Table 2 Presents the antigenicity, allergenicity, and toxicity of the final selected CTL dominant epitopes.
Peptide | Allele | Peptide length | Start | End | Antigenicity | Allergenicity | Toxicity | |
|---|---|---|---|---|---|---|---|---|
VirB2 | SIAAIEPNL | HLA-A*02:01 | 9 | 25 | 33 | 1.2654 | NON-ALLERGEN | Non-Toxin |
VirB3 | AMLFGVPVI | HLA-A*02:01 | 9 | 28 | 36 | 0.4653 | NON-ALLERGEN | Non-Toxin |
ILPLIVPIV | HLA-A*02:01 | 9 | 56 | 64 | 1.4522 | NON-ALLERGEN | Non-Toxin | |
VirB6 | SISSAIFSR | HLA-A*11:01 | 9 | 224 | 232 | 0.4543 | NON-ALLERGEN | Non-Toxin |
BtpA | VLSEHFFSK | HLA-A*03:01 | 9 | 178 | 186 | 0.6603 | NON-ALLERGEN | Non-Toxin |
KVALNTSLK | HLA-A*03:01 | 9 | 229 | 237 | 0.7452 | NON-ALLERGEN | Non-Toxin | |
ALNTSLKSV | HLA-A*02:01 | 9 | 231 | 239 | 0.7004 | NON-ALLERGEN | Non-Toxin |
